Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 22
Phase 31

Trial Status

Completed4
Recruiting1

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT06940674Phase 3Recruiting
Adjunctive Cannabidiol for Recovery From Opioid Study
Opioid Use Disorder (OUD)
PrincipalinvestigatorStart date: 2025-06-13
NCT06206291Phase 2Completed
Cannabidiol in the Treatment of Opioid Use Disorder
Opioid Use Disorder
PrincipalinvestigatorStart date: 2023-10-04
NCT05269706Phase 1Completed
Investigation of the Pharmacokinetic Profile of CBD
Opioid Use Disorder
PrincipalinvestigatorStart date: 2022-05-18
NCT04567784Phase 2Completed
Neuroimaging and CBD for Opioid Use Disorder
Heroin AbuseOpioid Use DisorderOpioid-Related Disorders+1 more
PrincipalinvestigatorStart date: 2020-11-12

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Icahn School of Medicine at Mount Sinai

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

David Fiellin, MD

Yale University

Related
7 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use DisorderSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score23%

Jeffrey L Schnipper, MD, MPH

Brigham and Women's Hospital

Related
8 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder
Similarity Score15%

Walter Ling, M.D.

Friends Research Institute, Inc.

Related
28 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Zev Schuman-Olivier, MD

Cambridge Health Alliance

Related
14 trials

Shared therapeutic areas:

Opioid Use DisorderOpioid-Related Disorders
Similarity Score15%

Rajita Sinha, PhD

Yale University

Related
11 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Mark Greenwald, PhD

Wayne State University

Related
15 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Kenneth Silverman, Ph.D.

Johns Hopkins University

Related
8 trials

Shared therapeutic areas:

Opioid-Related DisordersOpioid Use Disorder

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Kenzie Preston, Ph.D.

National Institute on Drug Abuse (NIDA)

Related
9 trials

Shared therapeutic areas:

Opioid-Related DisordersHeroin Abuse

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Thomas R Kosten, M.D.

VA Connecticut Healthcare System

Related
10 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

James Zacny, Ph.D.

University of Chicago

Related
17 trials

Shared therapeutic areas:

Opioid-Related DisordersSubstance-Related Disorders

Worked with same sponsors:

National Institute on Drug Abuse (NIDA)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06940674Phase 3PrincipalInvestigator

Adjunctive Cannabidiol for Recovery From Opioid Study

Opioid Use Disorder (OUD)
Recruiting
NCT06206291Phase 2PrincipalInvestigator

Cannabidiol in the Treatment of Opioid Use Disorder

Opioid Use Disorder
Completed
NCT05269706Phase 1PrincipalInvestigator

Investigation of the Pharmacokinetic Profile of CBD

Opioid Use Disorder
Completed
NCT04567784Phase 2PrincipalInvestigator

Neuroimaging and CBD for Opioid Use Disorder

Heroin AbuseOpioid Use DisorderOpioid-Related Disorders+1 more
Completed
NCT01311778Phase 1PrincipalInvestigator

Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse

Opiate Addiction
Completed

All 5 trials loaded